focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.
Seem to be interested in a different area:
"GetGo Recycling Ltd is an innovative green technology company. Our mission is to play an essential role in reducing the impact of sewage pollution in lakes, rivers and seas, while creating electrical power to provide a safe and sustainable environment"
Why should they want to cause waves with PHE?
Sounds like a fishing trip. Why and on whose behalf? This outfit has not followed any of the rules in bringing this claim, which might mean they are trying to do it on the cheap.
"The Company has not had any dealings or any communication with GetGo informing the Company of the Claim. The Company became aware the Claim had been filed via a third party. There is no detail or information in the filing of the Claim. In addition, the Claimant (i) did not send to the Company a letter of claim in accordance with the Code of Practice for pre-action conduct in intellectual property disputes, (ii) has not filed Particulars of Claim in accordance with the Civil Procedure Rules applicable to actions in the High Court, and (iii) has not served the Claim on the Company."
RK
Yes PHE have brushed this off as being of little importance, but the combustion chamber is at the heart of this complex kit, and to have to go to another supplier at this stage may well induce delay. No one is going to drop everything to get a new chamber to PHE on the original schedule. It involves ceramics and special steels, and these do not just come off the shelf. We will see.
Carrot
Also interesting is the statement that "We were able to successfully isolate viable DTCs after the prior cryopreservation of BM samples.
PS I think you refer to the Abstract; peer reviews are not shared with anyone apart from authors.
Broom
I think the (easy) assumption was that AGL would very rapidly get taken up by clinicians, but this uptake remains slow, and at present progress is on the back of basic research, where its promise is huge. Note the rather coy admission that the recent RNS gave that the new platform was for research use only. I do not think research tools need FDA approval either. Remember also that it only has approval for Ca breast at present. Approval for use in other malignancies will be sought - viz ovary and prostate- which will increase the use of Parsortix greatly. We all thought the sky was the limit when AGL was 140 p . Sadly no!, but I think we are now headed in the right direction albeit more slowly than we hoped.
Tatty
Thanks for attending and the update. Until the demo at Bridgend performs as it should, we are all in suspense. Was anything said about a) use of tyre crumble as substrate, and b) just making electricity until hydrogen needs increase>?
Depressing There is no mention of the DMG in this report. Mention of the feedstock testing unit being made by an other firm to be completed in Q! 2024, but where is the DMG?. Where is the finance for the DMG? No mention of this either. Is progress so slow that there is nothing to say, or has PHE lost its focus, or both ? Is PHE to become an engineering services outfit instead? " Announced new Business Strategy in the Annual Report to develop revenue streams through provision of engineering services and being actively involved in developing capital projects using project finance methodology."
Although the departure of Keith might be for a host of reasons including ill health, I think he was over parted as CEO and one hoes that his replacement is an improvement.
And no, Swazer, i am not a troll, or deramper or anything else, just a LTH getting mightily p!ssed off.
Can anyone cheer me up now that Dr A is no longer around to provide his emollient spin on things?
The RNS confirms my worst fears. As rather coyly stated at the bottom of the RNS, this is a research tool at present, and despite all the hype, I cannot see AGL making serious money in the near future, if ever. Take over would only be for pennies over present SP.